Bromide

Bromide

SCHEMBL3797608

CCSN(SCC)C(=S)Cc1ccc(C[N+](C)(C)C)cc1.[Br-]

nearest known ligand 0.35

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 1/20 0.35
TDP1 Q9NUW8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5654877 0.78 ALDH1A1 (0.42) ALDH1A1TDP1
SCHEMBL15514625 0.75 CHRNB2 (0.36) ALDH1A1
Hydrochloric Acid SCHEMBL2909153 0.74 ALDH1A1 (0.48) KDM4EALDH1A1TDP1
SCHEMBL1079074 0.69
SCHEMBL4797252 0.66 ALDH1A1 (0.68) KDM4EALDH1A1TDP1
SCHEMBL5747742 0.65
Hydrochloric Acid SCHEMBL4795693 0.64 ALDH1A1 (0.74) KDM4EALDH1A1TDP1
SCHEMBL13509798 0.64 MGLL (0.44) KDM4EALDH1A1TDP1
SCHEMBL12858954 0.62 ALDH1A1 (0.56) KDM4EALDH1A1TDP1
SCHEMBL1079287 0.62 PHGDH (0.31) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7659321-B2 Photoinitiator anchored to silicate and use thereof to prepare polymer exfoliated silicate nanocomposite CORNELL RESEARCH FOUNDATION, INC. (US) 2010-02-09 US disclosed
US-20090018229-A1 Nanocomposites prepared using nanoadditive containing dispersed silicate layers or inorganic nanoparticles CORNELL RESEARCH FOUNDATION, INC. 2009-01-15 US disclosed
US-20090012199-A1 Photoinitiator anchored to silicate and use thereof to prepare polymer exfolidated silicate nanocomposite NATIONAL SCIENCE FOUNDATION 2009-01-08 US disclosed
WO-2006055373-A1 NANOCOMPOSITES PREPARED USING NANOADDITVE CONTAINING DISPERSED SILICATE LAYERS OR INORGANIC NANOPARTICLES CORNELL RESEARCH FOUNDATION, INC. (US) 2006-05-26 WO disclosed
WO-2006055372-A2 PHOTOINITIATOR ANCHORED TO SILICATE AND USE THEREOF TO PREPARE POLYMER EXFOLIATED SILICATE NANOCOMPOSITE CORNELL RESEARCH FOUNDATION, INC. (US) 2006-05-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090012199-A1 Photoinitiator anchored to silicate and use thereof to prepare polymer exfolidated silicate nanocomposite MSN, NAPA, SELE KDM4E 3352/4885ALDH1A1 3240/4885TDP1 1572/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.